Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
05/1996
05/17/1996WO1996014302A1 Pyrazole derivatives exhibiting anti-inflammatory and analgesic effects
05/17/1996WO1996014077A1 Peripheral nervous system specific sodium channels, dna encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
05/17/1996WO1996014066A1 A method of treating urinary bladder dysfunctions
05/17/1996CA2507753A1 Use of creatine or creatine analogs for the treatment of diseases of the nervous system
05/17/1996CA2204429A1 Porcine striatal cells and their use in treatment of neurological deficits due to neurodegenerative disease
05/17/1996CA2204428A1 Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases
05/17/1996CA2204427A1 Porcine mesencephalic cells and their use in treatment of neurological deficits due to neurodegenerative diseases
05/17/1996CA2203935A1 Transgenic organisms and their uses
05/17/1996CA2203664A1 Substituted tetracyclic oxazepine and thiazepine derivatives with 5-ht2 receptor affinity
05/17/1996CA2203661A1 Substituted tetracyclic azepine derivatives which have affinity for 5-ht2 receptors
05/15/1996EP0711769A1 Improved process for large-scale production of BMS 180048 and analogs
05/15/1996EP0711755A1 Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor antagonists
05/15/1996EP0711559A2 Use of phosphatidylserines for the manufacture of a medicament for improving cerebration
05/15/1996EP0711299A1 AZABICYCLOALKYL DERIVATIVES OF IMIDAZO(1,5-a)INDOL-3-ONE AS 5HT 3 ANTAGONISTS
05/15/1996EP0711296A1 IMIDAZOLYLALKYL DERIVATIVES OF IMIDAZOL(5,1-c)(1,4)BENZOXAZIN-1-ONE AND THEIR USE AS THERAPEUTIC AGENTS
05/15/1996EP0711293A1 Imidazolylalkyl derivatives of imidazo(1,5-a)indol-3-one and their use as therapeutic agents
05/15/1996EP0711292A1 Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity
05/15/1996EP0711291A1 N-(piperidinyl-1-alkyl)-substituted cyclohexane carboxylic acid amides as 5-ht1a receptor antagonists
05/15/1996EP0711289A1 Piperazine compounds used in therapy
05/15/1996EP0711288A1 Piperazine derivatives as alpha 1a-adrenergic receptor antagonists
05/15/1996EP0711284A1 2-benzoheterocyclyloxy or thiopropanolamine derivatives with adreno receptor agonist activity
05/15/1996EP0711283A1 Tetrahydro-1h-benzazepinones and hexahydroazepinones as selective cholecystokinin-b receptor antagonists
05/15/1996EP0711282A1 Compounds as pde iv and tnf inhibitors
05/15/1996EP0711281A1 4-phenyl-4-phenylpropyl(enyl)-piperidines as tachykinin antagonists
05/15/1996EP0711279A1 2-phenylpyrrole derivatives as dopamine d3 receptor antagonists
05/15/1996EP0711278A1 2-(2-hydroxyphenyl)-5-(n-phenylmethyl-aminomethyl)-pyrroles as antipsychotic agents
05/15/1996EP0711272A1 Indane and tetrahydronaphthalene derivatives as calcium channel antagonists
05/15/1996EP0711271A1 Aminoindanes and related compounds useful as calcium-channel antagonists
05/15/1996EP0711169A1 Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
05/15/1996EP0711168A1 Methods of treating apoptosis and associated conditions
05/15/1996EP0711167A1 Methods of enhancing opiate analgesic potency or detoxifying an opiate addict
05/15/1996EP0711154A1 Stabilized pharmaceutical composition containing bupropion
05/15/1996EP0711134A1 Medicinal for protection from neurological damage
05/15/1996EP0639192B1 (benzodioxan, benzofuran or benzopyran)-alkylamino] alkyl substituted guanidines as selective vascoconstrictors
05/15/1996EP0465565B1 Treatment of aids dementia, myelopathy and blindness
05/15/1996CN1122601A |1,2,4¨triazolo|4,3-a¨ quinoxaline derivatives, their preparation and use
05/15/1996CN1122338A Physical form of dihydro-2,3-benzodiazepine derivative
05/15/1996CN1122248A Insulin analog formulations
05/15/1996CN1122238A Full-natural health product for detoxifying cigarette and its producing method
05/15/1996CN1122223A Preparing method for program-controlled skin permeable plaster
05/14/1996US5516936 Inhibitors of kynureninase
05/14/1996US5516800 Administering combination of arachidonic and docosahexaenoic acids
05/14/1996US5516797 Suppressing graft rejection
05/14/1996US5516785 Anabaseine, stimulating brain cholinergic transmission
05/14/1996US5516774 Treating diseases characterized by excess renal reabsorption of water
05/14/1996US5516772 K-252 derivatives which enhance neurotrophin-induced activity
05/14/1996US5516653 Genetic engineering
05/14/1996US5516526 Compositions containing DMSO and Fructose 1,6-diphosphate
05/14/1996CA1338326C Compounds for the treatment of alzheimer's disease
05/09/1996WO1996013603A1 INTERLEUKIN-1 β CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-3 AND 4
05/09/1996WO1996013599A1 Nucleic acid transfer system
05/09/1996WO1996013592A2 Protein kinase npk-110
05/09/1996WO1996013518A1 Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor
05/09/1996WO1996013506A1 Protein kinase inhibitors for treatment of neurological disorders
05/09/1996WO1996013501A1 Heterocycle substituted propenoic acid derivatives as nmda antagonists
05/09/1996WO1996013500A1 Bisarylcarbinol derivatives as inhibitors of leukotriene biosynthesis
05/09/1996WO1996013492A1 6-polyfluoroalkoxy and 6-polyfluoroalkyl-2-aminobenzothiazole derivatives
05/09/1996WO1996013484A1 Azetidinone derivatives for the treatment of atherosclerosis
05/09/1996WO1996013257A1 Use of receptor potentiators
05/09/1996WO1996013168A1 Method for treating anxiety
05/09/1996WO1996013167A1 Method for treating anxiety
05/09/1996WO1996013166A1 Method for treating anxiety
05/09/1996CA2203910A1 Novel protein kinase (npk-110)
05/09/1996CA2203767A1 Protein kinase inhibitors for treatment of neurological disorders
05/09/1996CA2202781A1 Method for treating anxiety
05/09/1996CA2202776A1 Method for treating anxiety
05/09/1996CA2200886A1 Use of ner receptors potentiators
05/09/1996CA2161046A1 Process for large-scale production of bms 180048 and analogs
05/08/1996EP0710669A1 Novel protein having avidity with heparin-binding growth factor
05/08/1996EP0710653A1 Salts of nefazodone having improved dissolution rates
05/08/1996EP0710241A1 Novel silylated benzylamine derivatives, salts thereof, methods of manufacture and pharmaceutical compositions containing them
05/08/1996EP0710239A1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
05/08/1996EP0710235A1 Endothelin antagonists
05/08/1996EP0710230A1 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists
05/08/1996EP0710229A1 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists
05/08/1996EP0710227A1 Vitamin d analogues
05/08/1996EP0710121A1 Method for treating multiple sclerosis
05/08/1996EP0710112A1 Use of vitamin D and derivatives thereof for the manufacture of a medicament for protection against neuron loss
05/08/1996EP0472526B1 5-AMINOCARBONYL-5H-DIBENZO a,d]CYCLOHEPTEN-5,10-IMINES FOR TREATMENT OF EPILEPSY AND COCAINE ADDICTION
05/08/1996CN1122136A Benzo|f¨quinoxalindione derivatives, their preparation and their use in drugs
05/08/1996CN1122135A Novel polycyclic systems, and derivatives thereof, as neurotransmitter release enhancers useful in the treatment of cognitive disorders
05/08/1996CN1121921A New benzothiadiazine compound, process for its preparation and the pharmaceutical compositions which contain it
05/07/1996US5514682 Fused imidazole and triazole derivatives as 5-HT1 receptor agonists
05/07/1996US5514680 Glycine receptor antagonists and the use thereof
05/07/1996US5514661 Autoimmune disease treatment
05/07/1996US5514653 Serpin-enzyme complex, treatment of alzheimer*s disease, inhibitor peptide
05/03/1996CA2160423A1 Salts of nefazodone having improved dissolution rates
05/02/1996WO1996012810A1 Hippocampus-associated proteins, dna sequences coding therefor and uses thereof
05/02/1996WO1996012805A1 Alk-7 (activin like kinase), a serine threonine kinase receptor
05/02/1996WO1996012797A1 Production and use of human and plant methyltransferases
05/02/1996WO1996012742A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases
05/02/1996WO1996012741A1 Binding agents to cd23
05/02/1996WO1996012737A2 Compositions and treatment for multiple sclerosis
05/02/1996WO1996012731A1 Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients
05/02/1996WO1996012724A1 Novel quinoxalindione derivatives, their production and use in medicaments
05/02/1996WO1996012715A1 Cyclopropachromenecarboxylate derivatives
05/02/1996WO1996012711A1 Heterocyclic compounds and their use
05/02/1996WO1996012710A1 Di-tert-butylphenol compounds with heterocyclic moiety, useful as anti-inflammatory agents
05/02/1996WO1996012501A1 Human hypoxanthine-(guanine) phosphoribosyl transferase-2
05/02/1996WO1996012497A1 Use of 2'-substituted oligonucleotides to down-regulating gene expression
1 ... 1649 1650 1651 1652 1653 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 1664 1665 1666 1667 1668 1669 ... 1833